Molecular Profile as an Outcome Predictor in Glioblastoma along with MRI Features and Surgical Resection: A Scoping Review

被引:4
|
作者
Papacocea, Serban Iancu [1 ]
Vrinceanu, Daniela [2 ]
Dumitru, Mihai [2 ]
Manole, Felicia [3 ]
Serboiu, Crenguta [4 ]
Papacocea, Marius Toma [1 ]
机构
[1] Carol Davila Univ Med & Pharm, Neurosurg Dept, Bucharest 020021, Romania
[2] Carol Davila Univ Med & Pharm, ENT Dept, Bucharest 020021, Romania
[3] Univ Oradea, Fac Med, ENT Dept, Oradea 410073, Romania
[4] Carol Davila Univ Med & Pharm, Cellular Biol & Histol Dept, Bucharest 020021, Romania
关键词
GBM; molecular; predictor; outcome; surgery; MGMT PROMOTER METHYLATION; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR RECEPTOR; TERT PROMOTER; PROGNOSTIC VALUE; MALIGNANT GLIOMA; IDH1; MUTATIONS; PHASE-II; TEMOZOLOMIDE; SURVIVAL;
D O I
10.3390/ijms25179714
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glioblastoma (GBM) is one of the most aggressive malignant tumors of the brain. We queried PubMed for articles about molecular predictor markers in GBM. This scoping review aims to analyze the most important outcome predictors in patients with GBM and to compare these factors in terms of absolute months of survival benefit and percentages. Performing a gross total resection for patients with GBM undergoing optimal chemo- and radiotherapy provides a significant benefit in overall survival compared to those patients who received a subtotal or partial resection. However, compared to IDH-Wildtype GBMs, patients with IDH-Mutant 1/2 GBMs have an increased survival. MGMT promoter methylation status is another strong outcome predictor for patients with GBM. In the reviewed literature, patients with methylated MGMT promoter lived approximately 50% to 90% longer than those with an unmethylated MGMT gene promoter. Moreover, KPS is an important predictor of survival and quality of life, demonstrating that we should refrain from aggressive surgery in important brain areas. As new therapies (such as TTFs) emerge, we are optimistic that the overall median survival will increase, even for IDH-Wildtype GBMs. In conclusion, molecular profiles are stronger outcome predictors than the extent of neurosurgical resection for GBM.
引用
收藏
页数:19
相关论文
共 46 条
  • [21] Impact of molecular and clinical variables on survival outcome with immunotherapy for glioblastoma patients: A systematic review and meta-analysis
    Hu, Wentao
    Liu, Hongyu
    Li, Ze
    Liu, Jialin
    Chen, Ling
    CNS NEUROSCIENCE & THERAPEUTICS, 2022, 28 (10) : 1476 - 1491
  • [22] A scoping review of participant reported outcome measures assessed during live and simulated surgical procedures
    Budden, Aaron K.
    Song, Sophia
    Henry, Amanda
    Wakefield, Claire E.
    Abbott, Jason A.
    AMERICAN JOURNAL OF SURGERY, 2025, 240
  • [23] MRI Features May Predict Molecular Features of Glioblastoma in Isocitrate Dehydrogenase Wild-Type Lower-Grade Gliomas
    Park, C. J.
    Han, K.
    Kim, H.
    Ahn, S. S.
    Choi, D.
    Park, Y. W.
    Chang, J. H.
    Kim, S. H.
    Cha, S.
    Lee, S-K
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2021, 42 (03) : 448 - 456
  • [24] Morphometric MRI features are associated with surgical outcome in mesial temporal lobe epilepsy with hippocampal sclerosis
    Fernandes Castilho Garcia, Maria Teresa
    Gaca, Larissa Botelho
    Sandim, Gabriel Barbosa
    Assuncao Leme, Idaiane Batista
    Carrete Junior, Henrique
    Centeno, Ricardo Silva
    Sato, Joao Ricardo
    Targas Yacubian, Elza Marcia
    EPILEPSY RESEARCH, 2017, 132 : 78 - 83
  • [25] Systematic review and pooled analysis assessing the association between elderly age and outcome following surgical resection of esophageal malignancy
    Markar, S. R.
    Karthikesalingam, A.
    Thrumurthy, S.
    Ho, A.
    Muallem, G.
    Low, D. E.
    DISEASES OF THE ESOPHAGUS, 2013, 26 (03) : 250 - 262
  • [26] Digital Phenotyping and Patient-Generated Health Data for Outcome Measurement in Surgical Care: A Scoping Review
    Jayakumar, Prakash
    Lin, Eugenia
    Galea, Vincent
    Mathew, Abraham J.
    Panda, Nikhil
    Vetter, Imelda
    Haynes, Alex B.
    JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (04): : 1 - 44
  • [27] Conventional MRI features of adult diffuse glioma molecular subtypes: a systematic review
    Lasocki, Arian
    Anjari, Mustafa
    Kokurcan, Suna Ors
    Thust, Stefanie C.
    NEURORADIOLOGY, 2021, 63 (03) : 353 - 362
  • [28] Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review Part 1-Molecular, morphological and clinical features
    Le Fevre, Clara
    Lhermitte, Benoit
    Ahle, Guido
    Chambrelant, Isabelle
    Cebula, Helene
    Antoni, Delphine
    Keller, Audrey
    Schott, Roland
    Thiery, Alicia
    Constans, Jean-Marc
    Noel, Georges
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 157
  • [29] Morphometric MRI features and surgical outcome in patients with epilepsy related to hippocampal sclerosis and low intellectual quotient
    Gaca, Larissa Botelho
    Fernandes Castilho Garcia, Maria Teresa
    Sandim, Gabriel Barbosa
    Assumption Leme, Idaiane Batista
    Silva Noffs, Maria Helena
    Carrete Junior, Henrique
    Centeno, Ricardo Silva
    Sato, Joao Ricardo
    Targas Yacubian, Elza Marcia
    EPILEPSY & BEHAVIOR, 2018, 82 : 144 - 149
  • [30] Molecular features unique to glioblastoma radiation resistant residual cells may affect patient outcome - a short report
    Kaur, Ekjot
    Goda, Jayant S.
    Ghorai, Atanu
    Salunkhe, Sameer
    Shetty, Prakash
    Moiyadi, Aliasgar V.
    Sridhar, Epari
    Mahajan, Abhishek
    Jalali, Rakesh
    Dutt, Shilpee
    CELLULAR ONCOLOGY, 2019, 42 (01) : 107 - 116